Anne Zeleniuch-Jacquotte

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc Defining the genomic signature of the parous breast
    Suraj Peri
    Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    BMC Med Genomics 5:46. 2012
  2. pmc Premenopausal serum androgens and breast cancer risk: a nested case-control study
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
    Breast Cancer Res 14:R32. 2012
  3. pmc Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine and Cancer Institute, New York University, New York, 10016 3240, USA
    Am J Epidemiol 172:36-46. 2010
  4. pmc Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer
    A Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Br J Cancer 105:1458-64. 2011
  5. ncbi request reprint Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York 10016, USA
    Cancer Epidemiol Biomarkers Prev 12:1531-5. 2003
  6. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
  7. pmc Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Lett 260:209-15. 2008
  8. ncbi request reprint Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, Room 539, 650 First Avenue, New York, NY 10016, USA
    Int J Cancer 114:323-7. 2005
  9. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
  10. pmc Endogenous hormones and coronary heart disease in postmenopausal women
    Yu Chen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, United States
    Atherosclerosis 216:414-9. 2011

Collaborators

Detail Information

Publications46

  1. pmc Defining the genomic signature of the parous breast
    Suraj Peri
    Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    BMC Med Genomics 5:46. 2012
    ..This phenomenon is thought to be associated with the development and differentiation of the breast during pregnancy...
  2. pmc Premenopausal serum androgens and breast cancer risk: a nested case-control study
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
    Breast Cancer Res 14:R32. 2012
    ..Prospective epidemiologic studies have consistently shown that levels of circulating androgens in postmenopausal women are positively associated with breast cancer risk. However, data in premenopausal women are limited...
  3. pmc Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine and Cancer Institute, New York University, New York, 10016 3240, USA
    Am J Epidemiol 172:36-46. 2010
    ....
  4. pmc Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer
    A Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Br J Cancer 105:1458-64. 2011
    ..One hypothesis is that the 2-hydroxy pathway is protective, whereas the 16α-hydroxy pathway is harmful...
  5. ncbi request reprint Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York 10016, USA
    Cancer Epidemiol Biomarkers Prev 12:1531-5. 2003
    ....
  6. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
    ..Indirect evidence from experimental and epidemiological studies suggests that prolactin may be involved in ovarian cancer development. However, the relationship between circulating prolactin levels and risk of ovarian cancer is unknown...
  7. pmc Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Lett 260:209-15. 2008
    ..These observations do not support a role for BSMI, APAI, TAQI, and FOKI polymorphisms in epithelial ovarian cancer in a predominantly Caucasian population...
  8. ncbi request reprint Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, Room 539, 650 First Avenue, New York, NY 10016, USA
    Int J Cancer 114:323-7. 2005
    ....
  9. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
    ..Our findings suggest that risk factors for chronic diseases (age, BMI, menopausal status, parity, NSAID use, family history of breast and ovarian cancer, and smoking) are associated with inflammation markers in healthy women...
  10. pmc Endogenous hormones and coronary heart disease in postmenopausal women
    Yu Chen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, United States
    Atherosclerosis 216:414-9. 2011
    ..These findings suggest that circulating estradiol and SHBG are not associated with CHD risk in postmenopausal women beyond what can be explained by the variation in hypertension status, BMI, and cholesterol...
  11. doi request reprint Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk
    Roy E Shore
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY, USA
    Int J Cancer 122:2101-5. 2008
    ..Further study of the XPC haplotypes and their interactions with smoking in relation to breast cancer risk is needed...
  12. doi request reprint Reproducibility of serum pituitary hormones in women
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NBV 9E2, New York, NY 10016, USA
    Cancer Epidemiol Biomarkers Prev 17:1880-3. 2008
    ....
  13. pmc Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer
    Paolo Toniolo
    Department of Obstetrics and Gynecology, NYU Cancer Institute, NYU School of Medicine, New York, NY, USA
    Cancer Res 70:6779-86. 2010
    ..Although the hormone seems to be a determinant of the reduced risk around or after age 50, it might not confer protection against, or it could even increase the risk of, cancers diagnosed in the years immediately following pregnancy...
  14. pmc Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
    ..The purpose of this study was to assess the association between circulating levels of inflammation mediators and subsequent risk of ovarian cancer...
  15. pmc Circulating estrogen metabolites and risk for breast cancer in premenopausal women
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Epidemiol Biomarkers Prev 18:2273-9. 2009
    ....
  16. ncbi request reprint Circulating enterolactone and risk of endometrial cancer
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, USA
    Int J Cancer 119:2376-81. 2006
    ..These results do not support a protective role of circulating lignans, in the range of levels observed, against endometrial cancer...
  17. pmc Reliability of serum assays of iron status in postmenopausal women
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Ann Epidemiol 17:354-8. 2007
    ..The aim of the study is to determine the reliability during a 2-year period of several newly developed iron-related assays to assess their potential for use in prospective epidemiologic studies...
  18. pmc Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women
    Oktawia P Wójcik
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Br J Nutr 104:629-32. 2010
    ..The CV was 7 %. These results indicate that the mean of two or more annual measurements of serum taurine is a sufficiently reliable measure of long-term serum levels that can be used in epidemiological studies...
  19. pmc Circulating soluble Fas levels and risk of ovarian cancer
    Arslan Akhmedkhanov
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA
    BMC Cancer 3:33. 2003
    ..The main objective of the present study was to evaluate serum sFas as a potential biomarker of ovarian cancer risk...
  20. ncbi request reprint Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NBV 9E2, New York, NY 10016, USA
    Cancer Epidemiol Biomarkers Prev 15:2123-30. 2006
    ..These data suggest that circulating pregnancy hormone levels may explain some of the ethnic differences in breast cancer risk...
  21. pmc Reliability of follicle-stimulating hormone measurements in serum
    Alan A Arslan
    New York University School of Medicine, New York, NY, USA
    Reprod Biol Endocrinol 1:49. 2003
    ..The objective of this study was to assess the reliability of FSH measurement using stored sera from an ongoing prospective cohort--the NYU Women's Health Study...
  22. pmc Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
    Yian Gu
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016 3240, USA
    Cancer Causes Control 21:1323-33. 2010
    ..This study suggests that dysregulated cytokines may be involved in B-NHL development...
  23. doi request reprint Serum taurine and risk of coronary heart disease: a prospective, nested case-control study
    Oktawia P Wójcik
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Eur J Nutr 52:169-78. 2013
    ..Taurine (2-aminoethanesulfonic acid), a molecule obtained from diet, is involved in bile acid conjugation, blood pressure regulation, anti-oxidation and anti-inflammation. We performed the first prospective study of taurine and CHD risk...
  24. pmc DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study
    Jennifer D Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, United States
    Cancer Epidemiol 34:717-23. 2010
    ..This suggests the potential for these serum markers to be used for breast cancer detection...
  25. pmc Genetic variants in hormone-related genes and risk of breast cancer
    Tess Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 8:e69367. 2013
    ..Our results suggest that these genetic variants do not have a strong effect on breast cancer risk. ..
  26. doi request reprint Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk
    Jennifer Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 17:1016-9. 2008
  27. pmc Reproducibility of serum cytokines and growth factors
    Yian Gu
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
    Cytokine 45:44-9. 2009
    ..Such an assumption is rarely tested although it may not be valid for all biomarkers. The objective of this study was to investigate the temporal reproducibility of a panel of cytokines and growth factors...
  28. pmc Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
    Tess V Clendenen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 18:275-81. 2009
    ..Our results suggest that endogenous estrone is associated with increased risk of colorectal cancer in postmenopausal women...
  29. ncbi request reprint Insulin-like growth factor I in pregnancy and maternal risk of breast cancer
    Annekatrin Lukanova
    Division of Epidemiology, Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NBV 9E2, New York, NY 10016, USA
    Cancer Epidemiol Biomarkers Prev 15:2489-93. 2006
    ....
  30. pmc Cox regression model with time-varying coefficients in nested case-control studies
    Mengling Liu
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Biostatistics 11:693-706. 2010
    ..The proposed inference procedure is evaluated in simulations and applied to an NCC study of breast cancer in the New York University Women's Health Study...
  31. doi request reprint Comparison of 3-point dixon imaging and fuzzy C-means clustering methods for breast density measurement
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Division of Epidemiology, New York, New York, USA
    J Magn Reson Imaging 38:474-81. 2013
    ..To assess two methods of fat and fibroglandular tissue (FGT) segmentation for measuring breast MRI FGT volume and FGT%, the volume percentage of FGT in the breast, in longitudinal studies...
  32. doi request reprint Estimation and selection of complex covariate effects in pooled nested case-control studies with heterogeneity
    Mengling Liu
    Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Biostatistics 14:682-94. 2013
    ..We conduct simulation studies to evaluate the performance of our proposed approaches in finite samples under various heterogeneity settings, and apply them to the pooled ovarian cancer study. ..
  33. pmc Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
    ..Cytokines are involved in the development of chronic diseases, including cancer. It is important to evaluate the temporal reproducibility of cytokines in plasma prior to conducting epidemiologic studies utilizing these markers...
  34. pmc Characterization of a genomic signature of pregnancy identified in the breast
    Ilana Belitskaya-Levy
    Division of Biostatistics, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Prev Res (Phila) 4:1457-64. 2011
    ..The genomic signature of pregnancy could be used as an intermediate marker to assess potential chemopreventive interventions with hormones mimicking the effects of pregnancy for prevention of breast cancer...
  35. pmc Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma
    Deepu Mirchandani
    New York University School of Medicine and NYU Cancer Institute, New York, NY, USA
    Anticancer Res 31:4401-5. 2011
    ..We examined by IHC the association between nuclear p27(KIP1) expression and hormone receptor status in T1N0M0 breast cancer...
  36. ncbi request reprint Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer
    Howard Hochster
    NYU School of Medicine, 160 East 32nd St, New York, NY 10016, USA
    J Clin Oncol 21:2703-7. 2003
    ..To determine the activity of biweekly oxaliplatin, combined with weekly bolus fluorouracil (FU) and low-dose leucovorin (LV) chemotherapy (bFOL), as first-line therapy for patients with metastatic colorectal cancer...
  37. pmc Promoter methylation and the detection of breast cancer
    Jennifer Brooks
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016 3240, USA
    Cancer Causes Control 20:1539-50. 2009
    ..In general, studies in well-defined populations, including appropriate controls and larger numbers are needed. Further, focus on the optimization of methods of methylation detection in small amounts of DNA is needed...
  38. pmc Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Ave, TH 528, New York, NY 10016, USA
    Arch Intern Med 170:791-802. 2010
    ..Obesity has been proposed as a risk factor for pancreatic cancer...
  39. pmc Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle
    Alana R Amarosa
    Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, 660 First Ave, 4th Floor, New York, NY 10016, USA
    Radiology 268:356-65. 2013
    ....
  40. ncbi request reprint Chemoprevention strategies for prostate cancer
    Maarten C Bosland
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    Eur J Cancer Prev 11:S18-27. 2002
    ..Such trials are an essential step in the development of antiprostate cancer chemoprevention agents...
  41. pmc Circulating vitamin d and risk of epithelial ovarian cancer
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Oncol 2009:672492. 2009
    ..59-2.01). In addition, there was no evidence of an interaction effect between VDR SNP genotype or haplotype and circulating 25(OH)D levels in relation to ovarian cancer risk, although more complex gene-environment interactions may exist...
  42. doi request reprint Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Divison of Epidemiology, New York, NY 10016, USA
    Magn Reson Imaging 31:1-9. 2013
    ..We conducted a pilot study to identify whether MRI parameters are sensitive to hormone-induced changes in the breast during the natural menstrual cycle and whether changes could also be observed during an oral contraceptive (OC) cycle...
  43. ncbi request reprint Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma
    Sandra R Reynolds
    Department of Dermatology, New York University School of Medicine, Kaplan Comprehensive Cancer Center, New York, New York 10016, USA
    Clin Cancer Res 9:657-62. 2003
    ..The following study was conducted to examine whether these responses are associated with improved clinical outcome in melanoma vaccine-treated patients...
  44. pmc Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women
    Xi Huang
    Department of Environmental Medicine, New York University School of Medicine and NYU Cancer Institute, 550 First Avenue, New York, NY 10016, USA
    Blood Cells Mol Dis 41:265-9. 2008
    ..The interrelationships between sTfR1 and prohepcidin or between ferritin and hepcidin suggest that ferritin- and sTfR1-sensed hepcidin conversion system exist in human body and maybe regulated at the post-translational level...
  45. pmc The potential protective effects of taurine on coronary heart disease
    Oktawia P Wójcik
    Department of Environmental Medicine, New York University School of Medicine, 650 FirstAvenue, New York, NY 10016, USA
    Atherosclerosis 208:19-25. 2010
    ..We also discuss shortcomings of the human studies that need to be addressed in the future. The identification of taurine as a preventive factor for CHD may be of great public health importance...
  46. ncbi request reprint Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients
    Marija Drobnjak
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Cancer Res 9:2613-9. 2003
    ..The abundance of p27, an inhibitor of cell proliferation, is controlled by Skp2-dependent proteolysis...